Gene · 10769
Papers1,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. | Cancer Biomark | 2024 | 40095483 | PubTator, text mining | PubMed |
| Identification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer. | Open Med (Wars) | 2024 | 39726813 | PubTator, text mining | PubMed |
| IAMSAM: image-based analysis of molecular signatures using the Segment Anything Model. | Genome Biol | 2024 | 39529142 | PubTator, text mining | PubMed |
| Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments. | J Mol Med (Berl) | 2024 | 39480521 | PubTator, text mining | PubMed |
| Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer. | Sci Rep | 2024 | 39390002 | PubTator, text mining | PubMed |
| Imaging spatial transcriptomics reveals molecular patterns of vulnerability to pathology in a transgenic α-synucleinopathy model. | bioRxiv | 2024 | 39372781 | PubTator, text mining | PubMed |
| PLK2-mediated phosphorylation of SQSTM1 S349 promotes aggregation of polyubiquitinated proteins upon proteasomal dysfunction. | Autophagy | 2024 | 39316746 | PubTator, text mining | PubMed |
| A Meta-analysis of Transcriptome Data to Investigate the Effect of Soy Isoflavones on Breast Cancer Cell. | Iran J Biotechnol | 2024 | 39220340 | PubTator, text mining | PubMed |
| RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy. | Cell Mol Life Sci | 2024 | 39162859 | PubTator, text mining | PubMed |
| Application of a Fluorescence Recovery-Based Polo-Like Kinase 1 Binding Assay to Polo-Like Kinase 2 and Polo-Like Kinase 3. | Biol Pharm Bull | 2024 | 38987177 | PubTator, text mining | PubMed |
| Emerging role of immunogenic cell death in cancer immunotherapy. | Front Immunol | 2024 | 38799433 | PubTator, text mining | PubMed |
| DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. | Kidney Int | 2024 | 38782200 | PubTator, text mining | PubMed |
| Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers. | Eur J Pharmacol | 2024 | 38614382 | PubTator, text mining | PubMed |
| The molecular basis of cell memory in mammals: The epigenetic cycle. | Sci Adv | 2024 | 38416817 | PubTator, text mining | PubMed |
| Heterogeneity of work alienation and its relationship with job embeddedness among Chinese nurses: a cross-sectional study using latent profile analysis. | BMC Nurs | 2024 | 38360635 | PubTator, text mining | PubMed |
| Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite. | Cell Chem Biol | 2024 | 38335967 | PubTator, text mining | PubMed |
| Perceptions of the importance of sports nutrition knowledge and barriers in implementing them: a qualitative study among track and field stakeholders in Sri Lanka. | BMC Nutr | 2024 | 38263161 | PubTator, text mining | PubMed |
| Therapeutic Approaches to Targeting Androgen Receptor Splice Variants. | Cells | 2024 | 38201308 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived TP53BP1, CD34, and PBX1 from human peripheral blood serve as potential biomarkers for the assessment and prediction of vascular aging. | Hereditas | 2024 | 38173016 | PubTator, text mining | PubMed |
| Genomic insights and advanced machine learning: characterizing autism spectrum disorder biomarkers and genetic interactions. | Metab Brain Dis | 2024 | 38153584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10769/papers?page=4